Daito Pharmaceutical Co., Ltd.TSE 4577

ダイト株式会社 · Pharmaceutical · FY ends May

Share price at FY-end
¥1,202
FY ending May 2026
Market cap at FY-end
¥34.7B
Dividend per share
¥40.0
Avg. director pay
¥43.2M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 株式会社日本カストディ銀行 2,934,600 10.18% ¥3.5B ¥117M
2 JAPAN ABSOLUTE VALUE FUND 2,688,300 9.32% ¥3.2B ¥108M
3 日本マスタートラスト信託銀行株式会社 1,770,500 6.14% ¥2.1B ¥70.8M
5 Wang Zhao 1,000,000 3.47% ¥1.2B ¥40.0M
6 株式会社オオツガ 800,600 2.78% ¥962M ¥32.0M
7 笹山 眞治郎 694,214 2.41% ¥834M ¥27.8M
8 二幸商事株式会社 640,000 2.22% ¥769M ¥25.6M
9 BNP Paribas Sydney 2S JASDEC Australian Residents 615,000 2.13% ¥739M ¥24.6M
10 ダイト従業員持株会 495,774 1.72% ¥596M ¥19.8M

Officers' holdings and pay

NameTitleSharesValuePay
大津賀保信 Chairman & Representative Director 57,710 ¥69.4M —
松森浩士 President & CEO, Representative Director 28,600 ¥34.4M —
日詰和重 Director 45,336 ¥54.5M —
Toru Ishida Director — — —
小松紀美子 Director — — —
山本一三 Director — — —
西能 淳 Director — — —
内田 稔 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending May 2026 ¥1,202 ¥107.49 11.2x ¥40.0 28,854,000
FY ending May 2025 ¥985 ¥62.74 15.7x ¥70.0 15,348,000
FY ending May 2024 ¥2,226 ¥210.00 10.6x ¥60.0 15,698,000
FY ending May 2023 ¥2,304 ¥250.39 9.2x ¥60.0 14,416,000
FY ending May 2022 ¥2,616 ¥335.41 7.8x ¥60.0 14,293,000
Source: annual securities reports on EDINET. Values are estimates. Methodology